Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using Venostan to Reduce Swelling After Ankle Surgery

Official title: The Efficacy and Safety of Venostan (Horse Chestnut Seed Extract Tablets) in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures: A Multicenter, Open-Label, Randomized Controlled Trial

Run by Beijing Jishuitan Hospital · NCT06872034 · Data updated 2026-11-12

This study is testing if Venostan, a natural extract, can help reduce swelling after ankle surgery for people with ankle fractures.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment290 (estimated)
SponsorBeijing Jishuitan Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedApril 16, 2025
Main results expectedJanuary 12, 2026
Study endsJanuary 12, 2026
Registry record updatedJuly 16, 2025
Trial IDNCT06872034 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have been diagnosed with specific types of ankle fractures and are scheduled for surgical intervention.

Probably not a fit

Patients with severe comorbidities, pre-existing lower limb edema, or those unable to walk independently prior to injury may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, open-label, randomized controlled trial aims to evaluate the efficacy and safety of Venostan, a horse chestnut seed extract, in reducing postoperative swelling in patients with ankle fractures undergoing internal fixation surgery. Eligible participants will be randomly assigned to receive either Venostan or standard treatment following their surgery. The study will assess changes in ankle circumference, range of motion, and any adverse events during follow-up. Data will be collected from multiple hospitals to ensure a diverse patient population.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce postoperative swelling and improve recovery outcomes for patients with ankle fractures.

How similar studies have gone: While the specific use of Venostan in this context may be novel, similar studies using horse chestnut extract for edema reduction have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥18 year old, no gender restriction;
* Diagnosed with ankle fracture confirmed by imaging data, AO classification: ---AO-43, AO-44-F3, AO-44;
* Scheduled to undergo open reduction and internal fixation surgery;
* Voluntary signing of the informed consent form.

Exclusion Criteria:

* Pregnant or lactating women;
* With contraindications to surgery;
* With other severe combined injuries or soft tissue infections;
* Severe multiple trauma: Injury Severity Score (ISS) \> 16;
* With concurrent fractures of the spine, pelvis, or ipsilateral or contralateral lower limbs;
* Pathological fractures;
* With peripheral vascular disease or deep vein thrombosis (DVT);
* With severe impairment of heart, lung, liver, or kidney function or abnormal coagulation function;
* Unable to walk independently before the injury;
* With pre-existing lower limb edema (e.g., due to liver cirrhosis, kidney disease, etc.) before the injury;
* With mental disorders or hyperalgesia;
* Allergic to any component of the investigational drug;
* Any contraindications that limit clinical evaluation and treatment of the patient;
* Deemed unsuitable for inclusion in this study by the investigator.

Where it's running

  • Beijing Jishuitan Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.